StockData
Annovis Bio, Inc. logo

Annovis Bio, Inc. (ANVS) bonds

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.74−0.01 (-0.91%)

Close on Nov 17, 2026Market cap $31.66MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Annovis Bio reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Annovis Bio's 10-K for the period ended Mar 31, 2019

IssueCouponAmount issued
Convertible promissory notes
Convertible
8.00%$530.00K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

See a number that looks wrong?